Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

193.49 -7.38 (-3.68%)
Streaming Delayed Price Updated: 3:12 PM EDT, Apr 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
Coinbase, DoorDash And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
Insulet Shares Jump After Q3 Earnings Surpass Expectations, Improved Annual Guidance ↗
 
Via Benzinga
News headline image
Insulet Reports Third Quarter 2022 Revenue Increase of 24% Year-Over-Year (29% Constant Currency1)
From Insulet Corporation
Via Business Wire
News headline image
Insulet Recognizes World Diabetes Day and Diabetes Awareness Month Throughout November
From Insulet Corporation
Via Business Wire
News headline image
FDA Approves Insulet's Omnipod Automated Insulin System For Patients Two Years & Above ↗
 
Via Benzinga
News headline image
What 8 Analyst Ratings Have To Say About Insulet ↗
Analysts have provided the following ratings for Insulet (NASDAQ:PODD) within the last quarter: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Analyst Ratings for Insulet ↗
Over the past 3 months, 6 analysts have published their opinion on Insulet (NASDAQ:PODD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
Insulet Posts Q2 Revenue Beat, Lifts FY22 Guidance ↗
 
Via Benzinga
News headline image
5 Analysts Have This to Say About Insulet ↗
Insulet (NASDAQ:PODD) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
4 Analysts Have This to Say About Insulet ↗
Analysts have provided the following ratings for Insulet (NASDAQ:PODD) within the last quarter: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022
From Insulet Corporation
Via Business Wire
News headline image
Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System
From Insulet Corporation
Via Business Wire
News headline image
Neurocrine Leads 5 Stocks To Watch In Sickly Market ↗
Neurocrine Biosciences leads five medical stocks showing resilience. 
Via Investor's Business Daily
News headline image
A Bullish Sign Appears On Insulet's Chart ↗
If history is any guide, there may be good fortune ahead for shares of Insulet (NASDAQ:PODD). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the... 
Via Benzinga
News headline image
$1000 Invested In Insulet 5 Years Ago Would Be Worth This Much Today ↗
Insulet (NASDAQ:PODD) has outperformed the market over the past 5 years by 24.25% on an annualized basis producing an average annual return of 35.42%. Currently, Insulet has a market capitalization of... 
Via Benzinga
News headline image
Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, August 22 ↗
Reuters Vodafone To Sell Hungarian Business For $1.8B: Report 
Via Benzinga
News headline image
FDA Clears Insulet's Omnipod 5 Automated Insulin Delivery System For Preschool Children ↗
The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ: PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with... 
Via Benzinga
News headline image
Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
News headline image
Recap: Insulet Q2 Earnings ↗
Insulet (NASDAQ:PODD) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Insulet missed estimated earnings by... 
Via Benzinga
News headline image
Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency1)
From Insulet Corporation
Via Business Wire
News headline image
Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System
From Insulet Corporation
Via Business Wire
The Healthcare Companies Fighting the World’s Biggest Killers
Palm Beach, FL – July 13, 2022 – FinancialNewsMedia.com News Commentary – Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the... 
Via FinancialNewsMedia
News headline image
Insulet to Announce Second Quarter 2022 Financial Results on August 4, 2022
From Insulet Corporation
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022 ↗
Upgrades 
Via Benzinga
News headline image
7 Stocks to Buy That Could Make You a Millionaire ↗
These seven of the best stocks to buy in June. TXG, BRKR, ETSY, PODD, MAR, RH and SEDG can make excellent investments. 
Via InvestorPlace
News headline image
Comparing Fitbits To Medical Devices? This Company Says Things Aren't Even Close ↗
The health and wellness industry focused on the well-being of the body, mind and spirit has captured the globe's attention. According to management consulting firm, Mckinsey & Co., the global wellness... 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.